We are live on
!
Find out more
BCM
Bayesian Capital Management Portfolio holdings
AUM
$156M
1-Year Est. Return
14.89%
This Fund
S&P 500
This Quarter
Est. Return
-0.77%
1 Year Est. Return
+14.89%
3 Year Est. Return
+106.87%
5 Year Est. Return
+133.82%
10 Year Est. Return
+1,146.09%
AUM
$670M
AUM Growth
+$354M
(+112%)
Cap. Flow
+$355M
Cap. Flow
% of AUM
52.94%
Top 10 Holdings %
Top 10 Hldgs %
13.36%
Holding
972
New
611
Increased
91
Reduced
51
Closed
218
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$35.1M |
| 2 |
ExxonMobil
XOM
|
+$7.27M |
| 3 |
Occidental Petroleum
OXY
|
+$6.26M |
| 4 |
Tyson Foods
TSN
|
+$6.08M |
| 5 |
Walt Disney
DIS
|
+$5.78M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FedEx
FDX
|
+$8.9M |
| 2 |
Comcast
CMCSA
|
+$7.55M |
| 3 |
Advanced Micro Devices
AMD
|
+$6.75M |
| 4 |
Oracle
ORCL
|
+$6.58M |
| 5 |
AT&T
T
|
+$6.04M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.25% |
| 2 | Consumer Discretionary | 11.52% |
| 3 | Healthcare | 10.6% |
| 4 | Industrials | 9.71% |
| 5 | Financials | 8.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OCDX
651
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
| $203K | 0.03% |
+10,900
| New | +$196K |
|
652
Autohome
ATHM
$2.6B
| $202K | 0.03% |
+6,656
| New | +$202K |
|
653
Kymera Therapeutics
KYMR
$10B
| $202K | 0.03% |
+4,780
| New | +$202K |
|
|
EXE
654
Expand Energy Corp
EXE
$22.7B
| $200K | 0.03% |
2,300
-16,500
| -88% | -$1.21M |
|
655
Constellium
CSTM
$3.71B
| $194K | 0.03% |
+10,799
| New | +$197K |
|
656
Hayward Holdings
HAYW
$3.02B
| $193K | 0.03% |
11,616
-6,400
| -36% | -$121K |
|
|
BINI
657
DELISTED
Bollinger Innovations
BINI
| – | – |
0
| – | – |
|
658
Lufax Holding
LU
$1.1B
| $188K | 0.03% |
8,450
-4,600
| -35% | -$101K |
|
659
Tilray
TLRY
$629M
| $188K | 0.03% |
2,420
-9,120
| -79% | -$571K |
|
660
Itaú Unibanco
ITUB
$83B
| $187K | 0.03% |
+37,162
| New | +$157K |
|
661
Aegon
AEG
$13.6B
| $186K | 0.03% |
+36,700
| New | +$185K |
|
|
OTLY
662
Oatly Group
OTLY
$481M
| $185K | 0.03% |
1,849
+1,149
| +164% | +$151K |
|
663
Recursion Pharmaceuticals
RXRX
$1.84B
| $184K | 0.03% |
+25,700
| New | +$273K |
|
664
Photronics
PLAB
$1.78B
| $183K | 0.03% |
+10,758
| New | +$194K |
|
665
Kodiak Sciences
KOD
$2.46B
| $182K | 0.03% |
+23,639
| New | +$923K |
|
|
BLDP
666
Ballard Power Systems
BLDP
$706M
| $181K | 0.03% |
+15,583
| New | +$166K |
|
|
CAN
667
Canaan Creative
CAN
$330M
| $176K | 0.03% |
32,335
+19,635
| +155% | +$98.1K |
|
668
Ginkgo Bioworks
DNA
$489M
| $176K | 0.03% |
1,093
+388
| +55% | +$75.5K |
|
669
ImmunityBio
IBRX
$8.9B
| $176K | 0.03% |
+31,300
| New | +$192K |
|
670
Repay Holdings
RPAY
$313M
| $173K | 0.03% |
11,684
+1,200
| +11% | +$19.8K |
|
671
LegalZoom.com
LZ
$1.04B
| $168K | 0.03% |
+11,900
| New | +$179K |
|
672
ADT
ADT
$5.45B
| $162K | 0.02% |
+21,317
| New | +$162K |
|
673
TechnipFMC
FTI
$29.9B
| $157K | 0.02% |
+20,200
| New | +$141K |
|
|
JMIA
674
Jumia Technologies
JMIA
$881M
| $156K | 0.02% |
+16,322
| New | +$146K |
|
|
WPRT
675
Westport Fuel Systems
WPRT
$35.1M
| $153K | 0.02% |
+9,690
| New | +$173K |
|
Similar funds
MCM
MFG
AFW
ADBIC
HSM
FWM
PIA
CCP
Bayesian Capital Management's Q1 2022 Portfolio in Review
As of Q1 2022, Bayesian Capital Management held 972 positions worth $670M, up 112% from $316M the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Bayesian Capital Management deployed $355M of net new capital in Q1 2022, opening 611 new positions and adding to 91 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 78,800 shares worth $35.6M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Oracle, an estimated $6.58M trimmed.
- Bayesian Capital Management's largest Q1 2022 buy was State Street SPDR S&P 500 ETF Trust: 78,800 shares worth $35.6M.
- Bayesian Capital Management added most to Coca-Cola in Q1 2022, an estimated $4.81M increase.
- Bayesian Capital Management's biggest Q1 2022 reduction was Oracle, cutting an estimated $6.58M.
- Bayesian Capital Management fully exited FedEx in Q1 2022, selling an estimated $8.9M.
- Bayesian Capital Management's ten largest holdings make up 13% of its $670M portfolio in Q1 2022.
- Bayesian Capital Management opened 611 new positions and closed 218 in Q1 2022.
- Bayesian Capital Management's portfolio value rose 112% quarter-over-quarter to $670M.
Based on Bayesian Capital Management's 13F filing for Q1 2022, filed 16 May 2022.